PeptideDB

ARS-1323-alkyne 2436544-27-1

ARS-1323-alkyne 2436544-27-1

CAS No.: 2436544-27-1

ARS-1323-alkyne, a switch-II pocket (S-IIP) inhibitor, a conformationally specific chemical reporter of the KRASG12C nuc
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

ARS-1323-alkyne, a switch-II pocket (S-IIP) inhibitor, a conformationally specific chemical reporter of the KRASG12C nucleotide state in living cells, is a switch-II pocket (S-IIP) inhibitor. A click chemistry reagent, ARS-1323-alkyne has an alkyne group and can be used to catalyze the azide-alkyne cycloaddition (CuAAc) of molecules that also contain an azide group.

Physicochemical Properties


Molecular Formula C28H27CLF2N6O3
Exact Mass 568.18
Elemental Analysis C, 59.10; H, 4.78; Cl, 6.23; F, 6.68; N, 14.77; O, 8.44
CAS # 2436544-27-1
Related CAS # ARS-1323;1698024-73-5
PubChem CID 138454781
Appearance Off-white to light brown solid powder
LogP 4.4
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 9
Rotatable Bond Count 8
Heavy Atom Count 40
Complexity 960
Defined Atom Stereocenter Count 0
InChi Key FCCFZQSNDSLLMI-UHFFFAOYSA-N
InChi Code

InChI=1S/C28H27ClF2N6O3/c1-4-11-35(3)22(40)9-10-32-28-33-26-17(27(34-28)37-14-12-36(13-15-37)21(39)5-2)16-18(29)23(25(26)31)24-19(30)7-6-8-20(24)38/h1,5-8,16,38H,2,9-15H2,3H3,(H,32,33,34)
Chemical Name

3-[[6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)-4-(4-prop-2-enoylpiperazin-1-yl)quinazolin-2-yl]amino]-N-methyl-N-prop-2-ynylpropanamide
Synonyms

ARS1323-Alkyne; ARS-1323 Alkyne; ARS 1323-Alkyne; ARS-1323-Alkyne
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets KRAS(G12C)
References

[1]. KRASG12C inhibition produces a driver-limited state revealing collateral dependencies. Sci Signal. 2019 May 28;12(583). pii: eaaw9450.


Solubility Data


Solubility (In Vitro) DMSO: ~250 mg/mL (~439.4 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (3.66 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (3.66 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)